Alma Fulurija
Corporate Officer/Principal at Ondek Pty Ltd.
Profile
Alma Fulurija is currently the Head of Immunology & Translational Research at Ondek Pty Ltd.
She previously worked as a Principal at Cytos Biotechnology AG.
Alma Fulurija active positions
| Companies | Position | Start |
|---|---|---|
Ondek Pty Ltd.
 Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Former positions of Alma Fulurija
| Companies | Position | End |
|---|---|---|
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Ondek Pty Ltd.
Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Health Technology |
- Stock Market
- Insiders
- Alma Fulurija
